Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001704917 | SCV000237519 | likely benign | not provided | 2020-12-21 | criteria provided, single submitter | clinical testing | |
Invitae | RCV000472425 | SCV000542350 | uncertain significance | Dilated cardiomyopathy 1G; Autosomal recessive limb-girdle muscular dystrophy type 2J | 2017-04-20 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002336482 | SCV002640220 | uncertain significance | Cardiovascular phenotype | 2019-09-29 | criteria provided, single submitter | clinical testing | The p.T15211S variant (also known as c.45631A>T), located in coding exon 153 of the TTN gene, results from an A to T substitution at nucleotide position 45631. The threonine at codon 15211 is replaced by serine, an amino acid with similar properties. This amino acid position is not well conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Revvity Omics, |
RCV001704917 | SCV003820219 | uncertain significance | not provided | 2019-07-11 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001704917 | SCV004033809 | uncertain significance | not provided | 2024-02-01 | criteria provided, single submitter | clinical testing | TTN: PM2, BP4 |